Related Experiment Video
Updated: Mar 31, 2026

Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
Genome-wide association study identifies SESTD1 as a novel risk gene for lithium-responsive bipolar disorder
J Song1, S E Bergen1,2, A Di Florio3
1Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Researchers identified a genetic variant in the SESTD1 gene associated with lithium-responsive bipolar disorder (BD). This finding offers insights into BD subtypes and potential therapeutic targets for lithium treatment.
Area of Science:
- Genetics
- Psychiatry
- Pharmacogenomics
Background:
- Lithium is a primary treatment for bipolar disorder (BD), but individual responses vary significantly.
- Lithium responders may represent a distinct subtype of BD, offering a target for genetic research.
- Understanding the genetic underpinnings of lithium response is crucial for personalized medicine in BD.
Purpose of the Study:
- To identify genetic variations influencing lithium response in bipolar disorder.
- To discover genetic variants associated with the risk of lithium-responsive BD.
- To explore the genetic architecture of BD subtypes based on lithium treatment efficacy.
Main Methods:
- Genome-wide association studies (GWAS) were conducted on patients with bipolar disorder from Sweden and the UK.
- GWAS compared lithium responders (subjective and objective definitions) with healthy controls.
- Meta-analysis and confirmatory genotyping were used to validate significant genetic associations.
Main Results:
- No significant associations were found for lithium response within bipolar disorder subjects.
- Two markers showed genome-wide significant associations when comparing lithium-responsive patients with controls.
- A validated intronic single-nucleotide polymorphism (SNP), rs116323614, in the SESTD1 gene on chromosome 2q31.2 was identified.
- The SESTD1 gene encodes a protein involved in phospholipid regulation, a known target of lithium treatment.
- Common variants explained a substantial proportion of variance in lithium-responsive BD (SNP heritability of 0.25-0.29).
Conclusions:
- A specific genetic variant in SESTD1 is associated with the risk of lithium-responsive bipolar disorder.
- This discovery supports the focus on lithium-responsive BD as a distinct subtype for understanding BD etiology.
- Findings suggest SESTD1 and phospholipid pathways as potential targets for future research and therapeutic strategies in BD.
More Related Videos
09:52Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
Published on: April 19, 2013
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Bipolar Disorder
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pleiotropy